Pixelgen Strengthens Asia-Pacific Presence with South Korea Deal

Pixelgen Technologies, Inc. and MDxK (Molecular Diagnostics Korea) Inc., part of DKSH Business Unit Technology, a leader in market expansion services, announced a distribution agreement to bring Pixelgen's Proxiome Kit to life sciences researchers in South Korea. The agreement further expands Pixelgen's growth in the Asia-Pacific region, following distribution agreements in Japan and Australia.

"South Korea is fast emerging as a life sciences hub of innovation, leading advancements in drug development and, more specifically, precision medicine," said Pixelgen Chief Marketing Officer Annika Branting. "We are honored to partner with such a high-caliber distributor as MDxK to bring our novel protein interatomics tools to researchers in the region."

Earlier this year, Pixelgen launched its Pixelgen Proxiome Kit, the first product to analyze the spatial location of cell surface protein markers, providing protein clustering, colocalization, and abundance data at an unprecedented scale. The kit helps researchers in fields such as immunology, hematology, and CAR-T and cancer research discover new biomarkers, better understand therapy mode of action, and assess single cell protein interactions.

"Pixelgen is filling an unmet need in the marketplace for technologies that help researchers understand how cells behave at the molecular level, at high throughput and scale," said Sungbo Shim, CEO of MDxK. "Existing tools lack the capability to support modern omics-scale studies, and we are thrilled to partner with Pixelgen to offer South Korea's researchers the latest innovative technologies for advancing basic science and precision medicine."